Figure 6.
(A) Structures of compounds with rigid linkers; (B) Cell viability assay for the indicated compounds; (C) Immunoblot of MDM2, p53 and GSPT1 following treatment of cells with DMSO or indicated compounds for 6 h.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.